Shares in Cannabis Sativa Inc (OTCMKTS:CBDS) have been on a three day rally after a recent consolidation from its annual high of 9.50 reached on January, 19th. CBDS recently found support at 5.60, trading as high as 7.55 today for a 35% swing in a span of just four trading sessions. Once CBDS broke above the 50DMA of 6.27 the bulls took control. In addition to the PPS movement, the RSI breaking above the 50-line is another indicator on the chart that appears bullish.
CBDS is just one of the several companies operating in an exciting and rapidly evolving marijuana industry, which we have been tenaciously and continuously tracking. A move back to the 52-week high of $9.50 from the last traded price of $6.79 could translate to another 40% gain opportunity.
MESQUITE, NV / ACCESSWIRE / January 9, 2017 / Cannabis Sativa Inc (OTCMKTS:CBDS) announces that its hi product line was featured in the Los Angeles Times business section in an article detailing trademarking and branding issues in the cannabis industry, on January 7, 2017. The link below leads to the article by James Koren and photo by Brian van der Brug / Los Angeles Times:
The story showcases the hi product line and the current United States Patent and Trademark Office (USPTO) stance that although cannabis is widely being legalized by states, it is still federally illegal, thereby precluding trademark registration for cannabis products. The article covers the tactic of cannabis companies trademarking ancillary products as the only course they can take to protect their intellectual property (IP).
The USPTOs stance on cannabis trademarks appears to differ somewhat from their stance on cannabis patents. On December 20, 2016, Cannabis Sativa was awarded Patent PP27,475 fora Cannabis Plant. The plant, Ecuadorian Sativa, is also known as CTA. This is one of the few cannabis strains allowed by the USPTO and was the result of seven years of legal effort. The Company plans to market or license the patented strain using the names Ecuadorian Sativa and CTA. The stance of the USPTO on whether Cannabis Sativa will be awarded the trademark Ecuadorian Sativa or CTA, or whether it is implied in the patent is the quandary.
“We would hope that the USPTO recognizes Cannabis Sativa’s ownership of the Equadorian Sativa and CTA names, as they appear to be implicitly granted in the patent”, Tobias said. As stated in Koren’s article, “The goal of trademark law is to prevent consumer confusion, and different companies can use the same name for products as long as their products are in different categories and wouldn’t cause confusion”, and that “trademark protection can apply not only to products a company makes now, but to products that a company might reasonably be expected to make later on — what trademark lawyers call the zone of natural expansion”. We are hopeful that industry awareness and articles such as Mr. Koren’s will help shift the USPTO’s stands on the issuance of trademarks for cannabis related products.
Cannabis Sativa has been active in pursuing IP and has successfully acquired a growing portfolio of Intellectual Property.
About Cannabis Sativa, Inc.
Cannabis Sativa, Inc. develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The Company plans to develop, produce and market products through joint ventures with companies licensed under state regulations applicable to cannabis businesses. It holds the license for a medicinal cannabis strain called NZT, a cannabis lozenge delivery methodology, and a cannabis trauma cream formula. The Company is also developing a third strain of cannabis plant named CT22. The Company also conducts its operations through its subsidiary, Wild Earth Naturals, Inc. (Wild Earth). Wild Earth is an herbal skin care products formulation and marketing company that plans to target the natural healthcare products market in the United States and abroad. It offers Go Deep, Go Deep EXTRA (GDX), Face Garden, Body Garden and Lip Garden.
Trading at over a $130 million dollar market cap, Cannabis Sativa, Inc. (OTCMKTS:CBDS) has been a high interest of StreetRegister.com due to its positioning itself in the cannabis sector. CBDS is seizing the cannabinoid products market from multiple angles of attack which makes it very diversified. It will remain among our tracked stocks in the marijuana space for the foreseeable future. Keep coming back to StreetRegister.com for updates on this and other pot stocks, and a whole lot more! Also get yourself signed up for our 100% free smallcap newsletter right away! Just enter your email address into the field below and hit Subscribe Now!